Heart Test Labs Files S-1/A Amendment

TL;DR

Heart Test Labs filed an S-1/A amendment on 9/27/24. Still registering securities.

AI Summary

Heart Test Laboratories, Inc. filed an S-1/A amendment on September 27, 2024, for its registration statement under the Securities Act of 1933. The company, incorporated in Texas with its principal office in Southlake, operates in the orthopedic, prosthetic & surgical appliances & supplies sector.

Why It Matters

This filing indicates ongoing regulatory activity for Heart Test Laboratories, Inc. as it progresses through the registration process for its securities.

Risk Assessment

Risk Level: medium — S-1/A filings are part of the IPO or secondary offering process, which inherently carries risks related to market reception and regulatory approval.

Key Numbers

• 333-272501 — SEC File Number (Identifies the specific registration statement with the SEC.)
• 26-1344466 — IRS Employer Identification Number (Company's tax identification number.)

Key Players & Entities

• Heart Test Laboratories, Inc. (company) — Registrant
• 333-272501 (dollar_amount) — SEC File Number
• 26-1344466 (dollar_amount) — IRS Employer Identification Number
• September 27, 2024 (date) — Filing Date

FAQ

Key Financial Figures

• $0.001 — 3 shares of its common stock, par value $0.001 per share (the “Common Stock&#x2
• $0 — e closing price of our IPO Warrants was $0. 06 per warrant. We expect this offer

Filing Documents

• ea0215597-01.htm (S-1/A) — 1608KB
• ea021559701ex1-1_hearttest.htm (EX-1.1) — 111KB
• ea021559701ex4-17_hearttest.htm (EX-4.17) — 113KB
• ea021559701ex5-1_hearttest.htm (EX-5.1) — 13KB
• ea021559701ex10-57_hearttest.htm (EX-10.57) — 202KB
• ea021559701ex23-1_hearttest.htm (EX-23.1) — 3KB
• ex5-1_001.jpg (GRAPHIC) — 10KB
• theart_logo.jpg (GRAPHIC) — 47KB
• timage_001.jpg (GRAPHIC) — 44KB
• 0001213900-24-082775.txt ( ) — 2190KB

RISK FACTORS

RISK FACTORS   25

USE OF PROCEEDS

USE OF PROCEEDS   34 DIVIDEND POLICY   35 CAPITALIZATION   36

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT   38 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS   40 DESCRIPTION OF OUR SECURITIES   45 DESCRIPTION OF THE SECURITIES WE ARE OFFERING   56 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO HOLDERS OF COMMON STOCK   57 PLAN OF DISTRIBUTION   62 DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES   68 LEGAL MATTERS   68 EXPERTS   68 WHERE YOU CAN FIND ADDITIONAL INFORMATION   68 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE   69 GLOSSARY OF TERMS   70 i Table of Contents ABOUT THIS PROSPECTUS The registration statement on Form S -1 of which this prospectus forms a part and that we have filed with the U.S. Securities and Exchange Commission (the “SEC”), includes exhibits that provide more detail of the matters discussed in this prospectus. You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under the heading “Where You Can Find Additional Information.” You should rely only on the information contained in this prospectus and the related exhibits, any prospectus supplement or amendment thereto and the documents, or to which we have referred you, before making your investment decision. Neither we, nor the placement agent engaged by us in connection with this offering, have authorized anyone to provide you with additional information or information different from that contained in this prospectus. We are offering to sell the Securities, and seeking offers to buy the Securities, only in jurisdictions where offers and sales are permitted. The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of the Securitie

View Full Filing

View this S-1/A filing on SEC EDGAR